Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182451 · ClinicalTrials.gov registry record · NA
Effect of Meso Wound Matrix in the Treatment of DFUs
A NA study, sponsored by SerenaGroup.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04182451 is a NA study that has completed, run by SerenaGroup. The registered enrollment target is 30 participants.
The verdict
NCT04182451, a NA study, has completed, sponsored by SerenaGroup.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a prospective trial designed to evaluate the use of Meso Wound Matrix (DSM Biomedical, Exton, PA) in Wagner grade 1 and 2 DFUs.
Interventions
- DEVICE Meso Wound Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-12-05 |
| Est. Completion | 2023-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04182451
The ClinicalTrials.gov registry entry for NCT04182451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SerenaGroup, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Meso Wound Matrix is the first listed.
NCT04182451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04182451 about?
NCT04182451 is a clinical study titled "Effect of Meso Wound Matrix in the Treatment of DFUs". This is a prospective trial designed to evaluate the use of Meso Wound Matrix (DSM Biomedical, Exton, PA) in Wagner grade 1 and 2 DFUs.
What is the current status of trial NCT04182451?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-12-05. Estimated completion is 2023-03-01.
What interventions are being tested in trial NCT04182451?
The interventions under investigation include: Meso Wound Matrix (DEVICE).
Who is sponsoring clinical trial NCT04182451?
This trial is sponsored by SerenaGroup, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.